BIO-key(R) Announces Fourth Quarter and FY 2013 Earnings Release and Conference Call Schedule
March 26 2014 - 1:20PM
Marketwired
BIO-key(R) Announces Fourth Quarter and FY 2013 Earnings Release
and Conference Call Schedule
WALL, NJ--(Marketwired - Mar 26, 2014) - BIO-key International,
Inc. (OTCQB: BKYI), a global leader in fingerprint biometric
identification solutions, advanced mobile credentialing and
identity verification technologies, today reported that the company
plans to release Fourth Quarter and FY 2013 financial results
on Tuesday April 1, 2014. In conjunction with the
release, BIO-key has scheduled a conference call, which will be
broadcast live over the Internet on Tuesday April 1st, at 10:00
a.m. Eastern Daylight Time.
What: BIO-key Fourth Quarter & FY 2013 - Conference Call
When: Tuesday April 1, 2014 - 10:00 a.m. Eastern Daylight
Time
Where: Live via phone by dialing 1-877-317-6789 (U.S.)
1-412-317-6789 (International) and asking for the BIO-key Call at
least 10 minutes prior to the start time. Or join the call
live over the Internet by logging on to the web address below.
Where: http://www.bio-key.com
A streaming audio replay of the webcast will be available
shortly after the call on www.bio-key.com for a period of thirty
days. You can also access the recorded call by dialing
1-877-344-7529 (U.S.) 1-412-317-0088 (International) and using
access code 10043330.
About BIO-key BIO-key International, Inc., headquartered in
Wall, New Jersey, develops and delivers advanced identification
solutions to commercial and government enterprises, integrators,
and custom application developers. BIO-key's award winning, high
performance, scalable, cost-effective and easy-to-deploy biometric
finger identification technology accurately identifies and
authenticates users of wireless and enterprise applications. Our
solutions are used in local embedded OEM products as well as some
of the world's largest identification deployments to improve
security, guarantee identity, and help reduce identity
theft. BIO-key's technology is offered directly or by market
leading partners around the world. (http://www.bio-key.com)
BIO-key Safe Harbor Statement Certain statements contained in
this press release may be construed as "forward-looking statements"
as defined in the Private Securities Litigation Reform Act of 1995
(the "Act"). The words "estimate," "project," "intends,"
"expects," "anticipates," "believes" and similar expressions are
intended to identify forward-looking statements. Such
forward-looking statements are made based on management's beliefs,
as well as assumptions made by, and information currently available
to, management pursuant to the "safe-harbor" provisions of the
Act. These statements are subject to certain risks and
uncertainties that may cause actual results to differ materially
from those projected on the basis of these statements. These
risks and uncertainties include, without limitation, our history of
losses and limited revenue, our ability to develop new products and
evolve existing ones, the impact on our business of the recent
financial crisis in the global capital markets and negative global
economic trends, our ability to attract and retain key
personnel. For a more complete description of these and other
risk factors that may affect the future performance of BIO-key
International, Inc., see "Risk Factors" in the Company's Annual
Report on Form 10-K for the year ended December 31, 2012 and its
other filings with the Securities and Exchange
Commission. Readers are cautioned not to place undue reliance
on these forward-looking statements, which speak only as of the
date made. The Company also undertakes no obligation to
disclose any revision to these forward-looking statements to
reflect events or circumstances after the date made or to reflect
the occurrence of unanticipated events.
Contact: BIO-key
International, Inc. Jay Meier VP Corp. Dev.
jay.meier@bio-key.com 651-789-6116
BIO key (NASDAQ:BKYI)
Historical Stock Chart
From Aug 2024 to Sep 2024
BIO key (NASDAQ:BKYI)
Historical Stock Chart
From Sep 2023 to Sep 2024